Serum zinc levels in patients with phlegmons as a marker of the severity of infection and the potential of zinc supplementation to reduce the risk of recurrence.

Abstract

We analyzed the serum zinc levels of 37 patients with 40 phlegmon lesions. The mean serum zinc level was 52.1±16.4μg/dL. The serum zinc level was negatively correlated with the C-reactive protein (CRP) level (r=-0.66) and white blood cell (WBC) count (r=-0.56). It was also positively correlated with the serum levels of albumin, hemoglobin, and hematocrit (r=0.57, 0.50, and 0.50, respectively). Patients with serum zinc levels of <60μg/dL had higher CRP levels and WBC counts (p<0.005 and p<0.05, respectively) and lower albumin, hemoglobin, and hematocrit levels (p<0.001, p<0.01, and p<0.01, respectively), and were more likely to be hospitalized (p<0.05) than those with serum zinc levels of ≥60μg/dL. Patients with low serum zinc levels were given zinc tablets. Three of the seven patients who developed recurrent phlegmons did not develop any further lesions after taking zinc tablets for >10months. Of the remaining patients, one only developed a minimal lesion, and another two experienced recurrence twice but did not have any further lesions for 10 and 15months, respectively. These findings indicate that in patients with phlegmons the serum zinc level is a suitable marker of the severity of infection, and zinc supplementation reduces the risk of further recurrence in patients whose lesions relapse.